EGFR and non-small cell lung carcinoma: By promoting Mcl-1 degradation, marinopyrrole A directly counters these survival signals, explaining the heightened sensitivity of EGFR-mutant and p-AKT-high non-small cell lung cancer (NSCLC) cells to Mcl-1 inhibition.